- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02628678
A Study to Evaluate the Effect of Diet on the Tolerability of FOS in Healthy Volunteers
August 29, 2016 updated by: Kaleido Biosciences
An Open-label Study to Evaluate the Effect of Diet on the Tolerability of FOS, a Commercially Available Prebiotic, in Healthy Volunteers
The primary objective of this study is to determine the 5-day tolerability of one commercially available prebiotic food ingredient, FOS, in healthy human subjects with and without diet control.
Study Overview
Study Type
Interventional
Enrollment (Actual)
7
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Massachusetts
-
Cambridge, Massachusetts, United States, 02138
- Kaleido Biosciences
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Be able to give written informed consent;
- Be male or female of any race, between 18 and 65 years of age;
- Have a BMI > 20 & < 27 kg/m2;
- Be willing to follow a controlled low fiber diet for a period of 11 days;
Exclusion Criteria:
- Are less than 18 and greater than 65 years of age;
- Are hypersensitive to any of the components of FOS;
- Are currently taking probiotic or prebiotic supplements, or have taken them in the past 28 days;
- Unwilling to avoid probiotics/prebiotics supplements for the duration of the study;
- Have a significant acute or chronic, unstable and untreated disease or any condition which contraindicates, in the investigators judgment, entry to the study;
- Subject is a smoker;
- Subject has a history of drug and/or alcohol abuse at the time of enrollment;
- Taken a medication that the investigator believes would interfere with the objectives of the study, pose a safety risk or confound the interpretation of the study results;
- Individuals who, in the opinion of the investigator, are considered to be poor attendees or unlikely for any reason to be able to comply with the trial;
- Subjects may not be receiving treatment involving experimental drugs;
- If the subject has been in a recent experimental trial, these must have been completed not less than 60 days prior to this study;
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: BASIC_SCIENCE
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
OTHER: Fructooligosaccharide (FOS)
Subjects will be required to take 8 grams of FOS per day for a total of 10 days.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Number of subjects with Adverse Events
Time Frame: 22 days
|
22 days
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
The effect of controlling diet on the tolerability of FOS by analyzing the gut microbiome
Time Frame: 22 days
|
22 days
|
Other Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
The effect of FOS on each subject's gut microbiome
Time Frame: 22 days
|
22 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2015
Primary Completion (ACTUAL)
December 1, 2015
Study Completion (ACTUAL)
December 1, 2015
Study Registration Dates
First Submitted
December 2, 2015
First Submitted That Met QC Criteria
December 10, 2015
First Posted (ESTIMATE)
December 11, 2015
Study Record Updates
Last Update Posted (ESTIMATE)
August 30, 2016
Last Update Submitted That Met QC Criteria
August 29, 2016
Last Verified
August 1, 2016
More Information
Terms related to this study
Other Study ID Numbers
- G006-HU-PD
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.